本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Protagonist Therapeutics Inc

86.59
+3.834.63%
盤後86.600.0100+0.01%19:55 EST
成交量:71.08萬
成交額:6,069.27萬
市值:54.13億
市盈率:131.20
高:86.85
開:82.32
低:77.00
收:82.76
52周最高:96.54
52周最低:33.70
股本:6,251.57萬
流通股本:4,315.48萬
量比:1.64
換手率:1.65%
股息:- -
股息率:- -
每股收益(TTM):0.6600
每股收益(LYR):4.23
淨資產收益率:7.80%
總資產收益率:1.82%
市淨率:8.39
市盈率(LYR):20.47

資料載入中...

2026/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2025/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/10/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/07/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

重要事件披露

Form 8-K - Current report